This website uses cookies
Read our Privacy policy and Terms of use for more information.
Nov 12, 2026
•
6 min read
The FDA requires a GLP-1 eye-risk warning, AstraZeneca buys vaccine biotech Omniose, and BIO rolls out a seven-point U.S. biotech agenda.
